24 Feb 2014
(MENAFN) Julphar, Ras Al Khaimah-based pharmaceutical products producer and distributor, reported a 14.9 percent growth in net profit of 2013 to reach USD62.71 million, according to the Emirates 24/7.
The company also reported a 15.4 percent growth in revenue year-on-year to reach USD3707 million.
Sales boosted by 19.4 percent year-on-year in 2013 driven by the private market sales.
Julphar Chairman, Sheikh Faisal Bin Saqr Al Qassimi, said: “The UAE is driving forward healthcare expansion at an international level and Julphar is proud to play a significant role in shaping the future of our industry. As the first and largest Emirati Pharmaceutical Company, we are positioned to help create a truly global platform for quality healthcare.”
08 Apr 2026
BBK awards over BD 1 Million to 273 winners in the February Al Hayrat Grand Prizes draw
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more